Company registration number 11203371 (England and Wales)
Ataraxia 2 Limited
Unaudited financial statements
For the period ended 31 October 2025
Ataraxia 2 Limited
Contents
Page
Statement of financial position
1
Notes to the financial statements
2 - 5
Ataraxia 2 Limited
Statement of financial position
As at 31 October 2025
31 October 2025
- 1 -
31 October 2025
31 December 2024
Notes
£
£
£
£
Fixed assets
Investments
3
-
0
622,887
Current assets
Debtors
4
492,799
114,221
Cash at bank and in hand
347,777
1,809
840,576
116,030
Creditors: amounts falling due within one year
5
(3,300)
(694,085)
Net current assets/(liabilities)
837,276
(578,055)
Net assets
837,276
44,832
Capital and reserves
Called up share capital
1,001
1,001
Profit and loss reserves
836,275
43,831
Total equity
837,276
44,832

For the financial period ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 17 December 2025 and are signed on its behalf by:
Mr C Parker
Director
Company registration number 11203371 (England and Wales)
Ataraxia 2 Limited
Notes to the financial statements
For the period ended 31 October 2025
- 2 -
1
Accounting policies
Company information

Ataraxia 2 Limited is a private company limited by shares incorporated in England and Wales. The registered office is Venture House, St Leonards Road, Allington, Maidstone, Kent, ME16 0LS.

1.1
Reporting period

These financial statements cover a shortened period. The reporting date was shortened from December to October to prepare for liquidation following the sale of the subsidiary. Therefore, the comparative amounts presented in the financial statements (including the related notes) are not entirely comparable.

1.2
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Going concern

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.true

The company ceased trading on 1 October 2025 and the financial statements have been prepared on a basis other than that of the going concern basis. This basis includes, where applicable, writing the company’s assets down to net realisable value. Provisions have also been made in respect of contracts which have become onerous at the reporting date. No provision has been made for the future costs of terminating the business unless such costs were committed to at the reporting date

1.4
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

Ataraxia 2 Limited
Notes to the financial statements (continued)
For the period ended 31 October 2025
1
Accounting policies
(Continued)
- 3 -
1.5
Fixed asset investments

Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable.

Ataraxia 2 Limited
Notes to the financial statements (continued)
For the period ended 31 October 2025
1
Accounting policies
(Continued)
- 4 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

2
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2025
2024
Number
Number
Total
0
1
3
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
-
0
622,887
Movements in fixed asset investments
Shares in associates
£
Cost or valuation
At 1 January 2025
622,887
Disposals
(622,887)
At 31 October 2025
-
Carrying amount
At 31 October 2025
-
At 31 December 2024
622,887
Ataraxia 2 Limited
Notes to the financial statements (continued)
For the period ended 31 October 2025
- 5 -
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
-
0
3,195
Other debtors
492,799
111,026
492,799
114,221

Included within other debtors is an amount of £232,563 which is due over one year (2024: £0.)

5
Creditors: amounts falling due within one year
2025
2024
£
£
Taxation and social security
-
0
15,696
Other creditors
3,300
678,389
3,300
694,085
6
Related party transactions

At the year end date the company owed £0 (2024: £475,401) P. G. Cullum. As at the year end date unpaid interest of £0 (2024: £117,198) was accrued on these loan notes.

At the year end date the company was due £0 (2024: £111,025) from a connected company. This is unsecured and is repayable on demand.

2025-10-31 2025-01-01 false false false 17 December 2025 CCH Software CCH Accounts Production 2025.300 No description of principal activity Mr Christian Parker Mr P G Cullum Mr David Alexander Lewis Clapp 11203371 2025-01-01 2025-10-31 11203371 2025-10-31 11203371 2024-12-31 11203371 core:CurrentFinancialInstruments core:WithinOneYear 2025-10-31 11203371 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 11203371 core:WithinOneYear 2025-10-31 11203371 core:WithinOneYear 2024-12-31 11203371 core:CurrentFinancialInstruments 2025-10-31 11203371 core:CurrentFinancialInstruments 2024-12-31 11203371 core:ShareCapital 2025-10-31 11203371 core:ShareCapital 2024-12-31 11203371 core:RetainedEarningsAccumulatedLosses 2025-10-31 11203371 core:RetainedEarningsAccumulatedLosses 2024-12-31 11203371 bus:Director1 2025-01-01 2025-10-31 11203371 2023-07-01 2024-12-31 11203371 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-10-31 11203371 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-10-31 11203371 bus:FRS102 2025-01-01 2025-10-31 11203371 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-10-31 11203371 bus:Director2 2025-01-01 2025-10-31 11203371 bus:Director3 2025-01-01 2025-10-31 11203371 bus:FullAccounts 2025-01-01 2025-10-31 xbrli:pure xbrli:shares iso4217:GBP